erythrocin-i.m. lösung
abbott gmbh - erythromycinethylsuccinat (ph.eur.) - lösung - erythromycinethylsuccinat (ph.eur.) 58.8mg
erythrocin n 500 filmtablette
abbott gmbh - erythromycinethylsuccinat (ph.eur.) - filmtablette - erythromycinethylsuccinat (ph.eur.) 588.24mg
erythrocin filmtablette
abbott gmbh - erythromycinstearat - filmtablette - erythromycinstearat 416.66mg
pd zahnplaque erkennungs-tabletten
ubert gmbh & co.kg (3091291) - erythrosin - kautablette - erythrosin (01359) 10 milligramm
blend-a-med plaque faerbetabletten s
blend-a-med forschung zweigniederlassung der procter & gamble gmbh (8000666) - erythrosin - kautablette - erythrosin (1359) 5 milligramm
blendax anti-belag faerbetabletten s
blend-a-med forschung zweigniederlassung der procter & gamble gmbh (8000666) - erythrosin - kautablette - erythrosin (1359) 5 milligramm
medikinet adult 40 mg
medice pharma gmbh & co. kg (3049544) - methylphenidathydrochlorid - hartkapsel, retardiert - teil 1 - hartkapsel, retardiert; methylphenidathydrochlorid (06085) 40 milligramm
medikinet adult 20 mg
medice pharma gmbh & co. kg (3049544) - methylphenidathydrochlorid - hartkapsel, retardiert - teil 1 - hartkapsel, retardiert; methylphenidathydrochlorid (06085) 20 milligramm
zejula
glaxosmithkline (ireland) limited - niraparib (tosilate monohydrate) - fallopian tube neoplasms; peritoneal neoplasms; ovarian neoplasms - antineoplastische mittel - zejula is indicated: , as monotherapy for the maintenance treatment of adult patients with advanced epithelial (figo stages iii and iv) high-grade ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. , as monotherapy for the maintenance treatment of adult patients with platinum sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum based chemotherapy.
oral-b zweifarb-plaque-indikator
gillette gruppe deutschland gmbh & co.ohg geschäftsbereich oral-b (3067074) - patentblau v; erythrosin - kautablette - teil 1 - kautablette; patentblau v (01358) 2,91 milligramm; erythrosin (01359) 5,217 milligramm